Abstract
Introduction: Medication adherence (MA) remains a major challenge in the long-term management of chronic conditions and may be associated with patients’ quality of life (QoL). Evidence regarding this relationship among adults in Albania remains limited. This study aimed to investigate the association between MA and QoL among adults receiving long-term pharmacological treatment in primary healthcare settings in Vlorë and Orikum, Albania. Methods: An observational, descriptive, cross-sectional multicenter study was conducted between June and December 2025 among 395 adults aged 18–64 years with at least one chronic condition requiring long-term pharmacological treatment. Participants were recruited consecutively from six primary healthcare centers. MA was assessed using the SMAQ tool, while QoL was evaluated using the WHOQOL-BREF. Associations were examined using chi-square/Fisher’s exact tests, Mann–Whitney U tests, binary logistic regression, and multiple linear regression. Statistical significance was set at p ≤ 0.05. Results: Overall, 22.5% of participants were classified as adherent and 77.5% as non-adherent. In multivariable analysis, higher educational attainment, being married/cohabiting, and taking up to two medications daily were independently associated with greater odds of adherence. Adherent participants had significantly higher scores for overall QoL, satisfaction with health, physical health, psychological health, and environmental health (all p ≤ 0.002), while no significant difference was observed for social relationships. In adjusted linear regression models, MA remained independently associated with overall QoL (B = 8.05, p = 0.026), psychological health (B = 9.07, p = 0.003), and environmental health (B = 5.43, p = 0.043), but not with physical health or social relationships. Higher educational attainment was consistently associated with better QoL across all domains, whereas multimorbidity was not independently associated with QoL outcomes. Discussion: Medication non-adherence was highly prevalent among adults with chronic conditions. MA was independently associated with selected dimensions of QoL, while educational attainment emerged as a consistent correlate of well-being. Conclusions: These findings highlight the relevance of adherence assessment and patient education in chronic disease management. Further longitudinal studies are needed to clarify the temporal relationships between medication adherence and QoL.
1. Introduction
Chronic conditions are long-lasting health problems that frequently require continuous clinical monitoring and prolonged pharmacological treatment. Chronic conditions are widespread globally and include, among others, cardiovascular diseases, diabetes, and chronic respiratory diseases; they represent a major global health burden and are important causes of morbidity, disability and mortality [1]. This critical health issue is also highly evident in Albania. According to the 2014 national health report, the overall burden of chronic conditions in the country surged by 34% between 1990 and 2010 [2]. This rising baseline is further supported by a self-reported survey by Kraja et al. (2016), which estimated the overall prevalence of chronic conditions at 22.8% [3]. Their findings highlighted that the youngest participants (aged 35–50 years) exhibited the lowest prevalence at approximately 10%. Due to the lack of major recent studies, the prevalence of chronic conditions and multimorbidity in Albania is currently unspecified [4], followed by participants aged 51–65 years and older adults with higher prevalence. Effective management of these conditions depends not only on the availability of appropriate treatments but also on patients’ ability to follow the recommended therapeutic regimen over time [5,6].
The World Health Organization (WHO) defines medication adherence (MA) as the degree to which a person’s medication-taking behavior aligns with the agreed therapeutic regimen [7]. MA is a complex and multidimensional behavior influenced by socioeconomic circumstances, healthcare-system characteristics, treatment-related factors, the underlying condition and individual patient characteristics [8]. Chronic diseases usually require long-term pharmacological treatment making sustained MA an essential component of effective disease management. Inadequate adherence may reduce the effectiveness of otherwise appropriate treatment and contribute to poorer disease control and preventable complications [9].
Quality of life (QoL) is another important outcome in the management of chronic conditions because it reflects the individual’s perception of physical, psychological, social and environmental well-being. Assessing QoL therefore provides a broader perspective on the impact of chronic conditions beyond clinical and biomedical outcomes. Multimorbidity, which represents the existence of two or more chronic conditions, may further affect these dimensions, as evidence indicates that an increasing number of chronic conditions is generally associated with poorer QoL [10].
MA has been associated with QoL among patients with chronic conditions, suggesting that adherence to prescribed treatment may contribute to better overall well-being and disease-related outcomes [9]. However, the strength and consistency of this relationship are not uniform across clinical populations. A positive association has been reported among patients with diabetes and hypertension attending primary healthcare services [11], whereas studies involving adults with epilepsy and rheumatic diseases have reported weak or non-significant relationships [12,13]. These differences may be related to the type and severity of the chronic condition, treatment complexity, sociodemographic characteristics and the instruments used to assess adherence and QoL.
Against this background, the present study aimed to examine the association between MA and QoL among adults aged 18–65 years living with chronic conditions and receiving long-term pharmacological treatment in primary healthcare centers in Vlorë and Orikum, Albania. Specifically, the study aimed to estimate the prevalence of medication adherence among adults living with one chronic condition or multimorbidity; to identify sociodemographic and clinical factors independently associated with medication adherence; to compare quality-of-life outcomes according to medication adherence and multimorbidity status; and to identify factors independently associated with overall quality of life and with each of the four WHOQOL-BREF domains.
2. Materials and Methods
2.1. Study Design
An observational, descriptive, cross-sectional, multicenter study with analytical approach was conducted to assess adults from 18 to 64 years old with at least one chronic condition in Vlorë, Albania. Data were collected from participants attending six primary healthcare centers located in Vlorë and Orikum, between June and December 2025. Potential participants were identified and approached at the participating healthcare centers by previously trained study personnel, who included one nurse from each of the six healthcare centers. Eligibility was assessed according to the predefined inclusion and exclusion criteria through a brief initial screening based on information provided by the patient. Eligible individuals received an explanation of the study and were invited to participate voluntarily.
After providing informed consent, participants completed the questionnaire inside the area of the healthcare center through Google Forms with the assistance of the trained staff nurse when it was necessary. Data collectors had been trained in the standardized administration of the questionnaire, including how to provide access to the electronic form and how to assist participants who experienced difficulties understanding individual questions, without influencing their responses.
A non-probability consecutive sampling method was used. During the study period, all patients attending the participating healthcare centers were screened according to the predefined eligibility criteria. Individuals who met the inclusion criteria were consecutively invited to participate until the end of the recruitment period. This approach reduced the potential for investigator-related selection and allowed all eligible patients presenting at the selected centers during the recruitment period an opportunity to be included.
The inclusion criteria were (a) age between 18 and 64 years; (b) diagnosis of at least one chronic condition requiring long-term pharmacological treatment; (c) ability to communicate in Albanian; (d) ability to understand the study purpose and complete the questionnaire independently or with minimal assistance; (e) provision of written informed consent.
Participants were excluded if (a) severe cognitive impairment or inability to complete the questionnaire reliably; (b) acute medical condition requiring immediate care; (c) refusal to participate or provide written informed consent.
Sample size calculation: Sample size was evaluated using an a priori power analysis for multiple linear regression (fixed model, R2 deviation from zero), assuming 12 predictor parameters, a two-sided significance level of 0.05, 80% statistical power, and a medium effect size (f2 = 0.15). The analysis indicated a minimum required sample size of 127 participants. The final analyzable sample of 395 participants therefore exceeded the minimum sample size required for the planned regression analyses.
2.2. Ethical Approval, Participant Information, and Informed Consent
The study was conducted in accordance with the principles of the Declaration of Helsinki [14]. Ethical and administrative approval for the implementation of the study and the use of the research instruments in six primary healthcare centers located in Vlorë and Orikum was granted by the Regional Directorate of the Vlorë Healthcare Services Operator (protocol code no. 2629/1; approval date: 26 November 2024).
Before participation, all eligible individuals received a Participant Information Sheet describing the study purpose, participant selection criteria, procedures, relevance of participation, and potential benefits. Written informed consent was subsequently obtained from each participant using the Participant Informed Consent Form. By signing the form, participants confirmed that they understood the study objectives and procedures, that their participation was voluntary, and that they could withdraw at any time without consequences or the need to provide justification. Participant anonymity and data confidentiality were maintained throughout the study. All collected information was used exclusively for scientific research purposes.
2.3. Data Collection and Instruments
Data were collected using a structured Google Forms questionnaire divided into three sections. The first section collected sociodemographic and relevant clinical characteristics of the participants. The second section assessed MA using the SMAQ tool linguistic validated into Albanian language. The third section evaluated QoL using the World Health Organization Quality of Life–BREF (WHOQOL-BREF) instrument developed by WHO in Geneva, Switzerland. The questionnaire was administered online via Google Forms (Web based version, Google LLC, Mountain View, CA, USA), and data collection was conducted by previously trained personnel.
MA was assessed using the SMAQ tool, a brief six-item self-reported instrument developed to evaluate medication-taking behaviors. The original validation study demonstrated satisfactory diagnostic performance of the SMAQ, with a sensitivity of 72%, a specificity of 91%, and a positive likelihood ratio of 7.94 [15]. The instrument also showed acceptable internal consistency, with a Cronbach’s alpha coefficient of 0.75. These findings support the validity and reliability of the SMAQ as a brief instrument for identifying medication non-adherence. The questionnaire assesses several dimensions of MA, including forgetfulness, missed doses, and intentional treatment interruptions. It comprises dichotomous (yes/no) and frequency-based items and evaluates medication-taking behavior over different recall periods, including the previous day, the previous week, the weekend, and the preceding three months [15]. Furthermore, in our sample the Cronbach alpha was (α = 0.813), which indicates good internal consistency of the SMAQ.
According to the original scoring criteria, participants are classified as adherent or non-adherent [15]. Any response indicative of non-adherence, such as missing more than two doses within a specified period (past week) or discontinuing medication for more than two consecutive days during the past three months, results in classification as non-adherent. Thus, the final SMAQ score was treated as a categorical variable, with participants classified as adherent or non-adherent [15]. To evaluate participants perceived QoL, the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire was utilized. The WHOQOL-BREF is a validated, cross-culturally applicable, 26-item self-report instrument derived from the longer WHOQOL-100 assessment [16]. It measures QoL over the preceding two weeks across four primary domains: physical health (7 items; evaluating pain, energy, sleep, and mobility), psychological health (6 items; assessing positive and negative emotions, self-esteem, thinking, learning, memory, and concentration), social relationships (3 items; examining personal relationships, social support, and sexual activity), and environment (8 items; covering safety, financial resources, physical environment, and healthcare accessibility) [16,17]. The remaining two items independently evaluate overall QoL and general health. All items are rated on a 5-point Likert scale, with higher scores reflecting better QoL. To assess the internal consistency reliability of the Albanian-language WHOQOL-BREF within the study population, Cronbach’s alpha (α) coefficients were calculated separately for each of its four domains using data from all 395 participants. The resulting coefficients were 0.669 for physical health, 0.832 for psychological health, 0.891 for social relationships, and 0.902 for environment.
2.4. Data Analysis
Data completeness was assessed before statistical analysis. All 395 participants had complete responses for the SMAQ items [15] and the WHOQOL-BREF outcomes, including overall quality of life, satisfaction with health, and all four WHOQOL-BREF domains [16]. Therefore, no missing-value imputation was required for the primary study instruments or their derived scores. Some missing values were present in individual clinical variables; analyses involving these variables were based on the available observations.
All statistical analyses were performed using IBM SPSS Statistics version 29.0 (IBM Corp., Armonk, NY, USA) and R statistical software version 4.5.2 (R Foundation for Statistical Computing, Vienna, Austria). Categorical variables were summarized as frequencies and percentages, whereas continuous variables were reported as means and standard deviations or medians with interquartile ranges, depending on data distribution. Associations between categorical variables were evaluated using the Pearson chi-square test or Fisher’s exact test, where appropriate. The distribution of continuous variables was assessed using the Shapiro–Wilk test. As the majority of quality-of-life variables deviated significantly from a normal distribution, non-parametric statistical methods were applied for the bivariate analyses. Differences in WHOQOL-BREF scores between two independent groups, including MA status and multimorbidity, were assessed using the Mann–Whitney U test. Binary logistic regression analysis was performed to identify independent predictors of MA. Variables included in the multivariable logistic regression model were selected based on their clinical relevance, theoretical considerations, and previous literature regarding medication adherence. These included sex, age, educational level, employment status, marital status, multimorbidity, and number of medications taken daily, regardless of their statistical significance in the bivariate analyses. Adjusted odds ratios (AORs) with 95% confidence intervals (95% CI) were reported. Multiple linear regression analyses were subsequently performed to identify factors independently associated with overall quality of life and each of the four WHOQOL-BREF domains: physical health, psychological health, social relationships, and environmental health. Regression coefficients (β), standard errors (SE), 95% CI, and corresponding p-values were reported. Model assumptions, including multicollinearity, were evaluated before interpreting the final models. Statistical significance was defined as a two-sided p-value ≤ 0.05.
3. Results
3.1. Sociodemographic Characteristics
The study included 395 adults living with chronic conditions. Most participants were recruited from primary healthcare centers in Vlorë (n = 332; 84.1%), whereas 63 participants (15.9%) were from Orikum. Of the participants, 71.1% were female and 28.9% were male.
The largest age group was 45–54 years (28.1%), followed by those aged 18–24 years (23.3%) and 55–64 years (18.2%). More than half of the participants had completed higher education (56.7%), while 31.9% had secondary education and 11.4% had primary education.
Regarding employment status, 22.3% were employed in the public sector, 22.3% were unemployed, 17.2% were employed in the private sector, 16.5% were self-employed, 16.5% were students, and 5.3% were receiving social assistance. Approximately half of the participants were married or living with a partner (50.9%), while 37.2% were single and 11.9% were divorced or widowed (Table 1).
Table 1.
Sociodemographic characteristics of the study participants (n = 395).
Clinical and Treatment Characteristics
Most participants (78.7%, n = 311) had one chronic condition, whereas 21.3% (n = 84) reported two or more conditions. The mean number of chronic conditions was 1.32 ± 0.71. Hypertension was the most common chronic condition (25.1%), followed by allergies (14.4%), diabetes mellitus (13.7%), and chronic anxiety/depression (11.9%), while 24.1% of participants reported other chronic conditions. Regarding daily medication, 87.7% (n = 347) of participants reported taking up to two medications per day, whereas 12.2% (n = 48) reported taking over two medications per day. The mean daily medication was 1.55 ± 0.89 medications. Antihypertensive/cardiovascular drugs were the most frequently used medication class (34.4%), followed by antidiabetic medications (16.2%), depression and anxiety medications (14.2%), respiratory medications (11.1%), lipid-lowering agents (11.4%), vitamins or supplements (5.6%), and while 27.8% of participants reported using other medications. The findings are shown in Table 2.
Table 2.
Clinical and treatment characteristics of participants.
3.2. Adherence to Medication and Associated Factors
MA was assessed using the SMAQ tool. According to the original SMAQ scoring algorithm, 89 participants (22.5%) were classified as adherent, whereas 306 participants (77.5%) were classified as non-adherent, as shown in Table 3.
Table 3.
Medication adherence according to the SMAQ questionnaire (n = 395).
To evaluate the association between MA and other sociodemographic factors, the χ2 test or Fisher’s test was applied. MA did not differ significantly according to gender (χ2 = 0.122, p = 0.727). In contrast, significant associations were observed for age group (χ2 = 36.773, p < 0.001), educational level (χ2 = 30.841, p < 0.001), employment status (χ2 = 13.413, p = 0.020), marital status (χ2 = 25.727, p < 0.001), multimorbidity (χ2 = 1.336, p = 0.248), and the number of medications taken daily (χ2 = 10.209, p = 0.001). Higher adherence was generally observed among younger participants, those with higher educational attainment, individuals with a single chronic condition, single participants and participants taking two or fewer medications per day, as shown in Table 4.
Table 4.
Association between medication adherence and sociodemographic and clinical characteristics (n = 395).
A multivariable binary logistic regression analysis was conducted to identify independent predictors of MA in adults with chronic diseases. After adjusting for sex, age, education, employment status, marital status, multimorbidity, and number of medications, it was observed that education, marital status, and number of medications remained significant predictors of MA. The results of the regression model are presented in Table 5.
Table 5.
Multivariable binary logistic regression analysis of factors associated with medication adherence (n = 395).
The overall model was statistically significant (Omnibus χ2(11) = 70.12, p < 0.001), explaining 16.3% of the variance according to the Cox and Snell R2 and 24.8% according to the Nagelkerke R2. The model correctly classified 80.5% of participants.
Participants with secondary or lower education had significantly lower odds of being adherent than those with higher education (AOR = 0.29, 95% CI: 0.15–0.55, p < 0.001). Married or cohabiting participants had higher odds of adherence compared with single participants (AOR = 4.78, 95% CI: 1.47–15.58, p = 0.009). In addition, participants taking up to two medications had higher odds of adherence than those taking more than two medications (AOR = 4.98, 95% CI: 1.10–22.46, p = 0.037). Sex, age group, employment status, and multimorbidity were not independently associated with MA in the adjusted model.
3.3. Quality of Life (WHOQOL-BREF) and Its Association with Medication Adherence
Descriptive statistics for the WHOQOL-BREF scores are presented in Table 6. Because the WHOQOL-BREF scores were not normally distributed, both mean ± standard deviation and median with interquartile range are reported.
Table 6.
Descriptive statistics of WHOQOL-BREF scores.
Participants reported a mean overall QoL score of 64.75 ± 29.42, while the mean overall satisfaction with health score was 51.46 ± 29.04. Among the WHOQOL-BREF domains, the highest mean score was observed for the psychological health domain (58.48 ± 23.84), followed by the physical health (53.64 ± 17.30), environmental (52.71 ± 21.74), and social relationships (52.57 ± 27.54) domains. Median values were generally consistent with the corresponding mean scores, indicating a similar central tendency across the domains despite the non-normal distribution of the data. Table 7 presents the comparison of WHOQOL-BREF domain scores between participants with one chronic condition and those with two or more chronic conditions using the Mann–Whitney U test.
Table 7.
Comparison of WHOQOL-BREF domain scores according to multimorbidity status (Mann–Whitney U test).
Mann–Whitney U tests showed no statistically significant differences between the two groups across any of the WHOQOL-BREF domains. Participants with one chronic condition had slightly higher mean ranks for overall QoL (200.18 vs. 189.92, p = 0.448), overall satisfaction with health (199.95 vs. 190.78, p = 0.500), physical health (200.26 vs. 189.64, p = 0.446), environmental health (199.02 vs. 194.22, p = 0.731), and social relationships (199.90 vs. 190.96, p = 0.521), whereas psychological health scores were nearly identical between the two groups (198.01 vs. 197.96, p = 0.997). Overall, multimorbidity was not associated with significant differences in QoL across any WHOQOL-BREF domain.
The same test (Mann–Whitney) was applied to evaluate the association between medication adherence and QoL measured by WHOQOL-BREF, as shown in Table 8.
Table 8.
Comparison of WHOQOL-BREF domain scores between adherent and non-adherent participants (Mann–Whitney U test).
Participants classified as adherent had significantly higher mean ranks than non-adherent participants for overall QoL (U = 9651.5, Z = −4.337, p < 0.001, r = 0.218), overall satisfaction with health (U = 10,793.0, Z = −3.076, p = 0.002, r = 0.155), physical health (U = 10,629.0, Z = −3.176, p = 0.001, r = 0.160), psychological health (U = 10,306.5, Z = −3.514, p < 0.001, r = 0.177), and environmental health (U = 10,194.5, Z = −3.629, p < 0.001, r = 0.183). No statistically significant difference was observed between adherent and non-adherent participants in the social relationship’s domain (U = 12,554.0, Z = −1.129, p = 0.259, r = 0.057).
3.4. Independent Predictors of Quality of Life
Multiple linear regression analyses were performed to identify factors independently associated with overall quality of life and the four WHOQOL-BREF domains: physical health, psychological health, social relationships, and environmental health. In this analysis, overall quality of life refers specifically to the first general WHOQOL-BREF item and not to a composite total WHOQOL-BREF score. The results of the five regression models are presented in Table 9, Table 10, Table 11, Table 12 and Table 13.
Table 9.
Multiple linear regression analysis of factors associated with overall quality of life (n = 395).
Table 10.
Multiple linear regression analysis of factors associated with physical health (WHOQOL-BREF).
Table 11.
Multiple linear regression predicting psychological health domain (WHOQOL-BREF).
Table 12.
Multiple linear regression predicting the environmental domain of quality of life (WHOQOL-BREF).
Table 13.
Multiple linear regression predicting the social relationships domain of quality of life (WHOQOL-BREF).
3.4.1. Overall Quality of Life
The multiple linear regression model for overall quality of life was statistically significant, F (14, 380) = 4.953, p < 0.001, explaining 15.4% of the variance in overall quality of life (R2 = 0.154; adjusted R2 = 0.123). Medication adherence (MA) was independently associated with overall quality of life (B = 8.05, β = 0.114, 95% CI: 0.962–15.138, p = 0.026), with adherent participants reporting higher overall quality-of-life scores. Educational attainment was also significantly associated with overall quality of life. Compared with participants with primary education, those with secondary education (B = 18.15, β = 0.288, 95% CI: 8.419–27.876, p < 0.001) and higher education (B = 26.64, β = 0.449, 95% CI: 16.678–36.609, p < 0.001) had higher overall quality-of-life scores. Participants aged 35–44 years had significantly lower overall quality-of-life scores than those aged 18–24 years (B = −14.65, β = −0.175, 95% CI: −25.255–−4.047, p = 0.007). Married or cohabiting participants reported higher overall quality-of-life scores than single participants (B = 8.23, β = 0.140, 95% CI: 1.142–15.322, p = 0.023). Neither multimorbidity, defined as two or more chronic conditions, compared with one chronic condition (B = −3.73, β = −0.033, 95% CI: −14.958–7.506, p = 0.515), nor having more than two medications compared with up to two medications (B = 1.61, β = 0.018, 95% CI: −7.302–10.513, p = 0.723) was significantly associated with overall quality of life. Sex, the other age groups, employment status, and divorced/widowed status were also not significantly associated with overall quality of life (p > 0.05).
3.4.2. Physical Health
The multiple linear regression model for physical health was statistically significant, F(14, 380) = 3.810, p < 0.001, explaining 12.3% of the variance in physical health scores (R2 = 0.123; adjusted R2 = 0.091). Educational attainment was significantly associated with physical health. Compared with participants with primary education, those with secondary education (B = 8.63, β = 0.233, 95% CI: 2.802–14.457, p = 0.004) and higher education (B = 10.74, β = 0.308, 95% CI: 4.766–16.704, p < 0.001) had higher physical health scores. Divorced or widowed participants had significantly lower physical health scores than single participants (B = −10.01, β = −0.188, 95% CI: −16.126–−3.899, p = 0.001). Medication adherence (MA) was not independently associated with physical health after adjustment (B = 4.17, β = 0.101, 95% CI: −0.079–8.412, p = 0.054). Sex, age group, employment status, marital status, multimorbidity, and number of medications were not significantly associated with physical health (p > 0.05).
3.4.3. Psychological Health
The multiple linear regression model for psychological health was statistically significant, F (14, 380) = 3.626, p < 0.001, explaining 11.8% of the variance in psychological health scores (R2 = 0.118; adjusted R2 = 0.085). Medication adherence (MA) was independently associated with psychological health (B = 9.07, β = 0.159, 95% CI: 3.204–14.937, p = 0.003), with adherent participants reporting higher psychological health scores. Educational attainment was also significantly associated with psychological health. Compared with participants with primary education, those with secondary education (B = 12.63, β = 0.247, 95% CI: 4.578–20.684, p = 0.002) and higher education (B = 13.38, β = 0.278, 95% CI: 5.133–21.630, p = 0.002) had higher psychological health scores. Divorced or widowed participants had lower psychological health scores than single participants (B = −8.84, β = −0.120, 95% CI: −17.284–−0.389, p = 0.040). Multimorbidity showed a borderline but non-significant association with psychological health (B = −7.83, β = −0.086, 95% CI: −17.123–1.471, p = 0.099). Sex, age group, employment status, marital status, and number of medications were not significantly associated with psychological health (p > 0.05).
3.4.4. Environmental Health
The multiple linear regression model for environmental health was statistically significant, F (14, 380) = 4.614, p < 0.001, explaining 14.5% of the variance in environmental health scores (R2 = 0.145; adjusted R2 = 0.114). Medication adherence (MA) was independently associated with environmental health (B = 5.43, β = 0.104, 95% CI: 0.162–10.695, p = 0.043), with adherent participants reporting higher environmental health scores. Sex was also significantly associated with environmental health, with male participants reporting higher scores than female participants (B = 7.00, β = 0.146, 95% CI: 2.254–11.750, p = 0.004). Educational attainment was significantly associated with environmental health; compared with primary education, participants with secondary education (B = 12.65, β = 0.272, 95% CI: 5.425–19.883, p = 0.001) and higher education (B = 14.88, β = 0.340, 95% CI: 7.476–22.285, p < 0.001) had higher scores. Married or cohabiting participants had higher environmental health scores than single participants (B = 5.58, β = 0.128, 95% CI: 0.310–10.847, p = 0.038), whereas divorced or widowed participants had lower scores (B = −8.38, β = −0.125, 95% CI: −15.959–−0.791, p = 0.031). Age group, employment status, multimorbidity, and number of medications were not significantly associated with environmental health (p > 0.05).
3.4.5. Social Relationships
The multiple linear regression model for social relationships was statistically significant, F(14, 380) = 3.907, p < 0.001, explaining 12.6% of the variance in social relationships scores (R2 = 0.126; adjusted R2 = 0.094). Medication adherence (MA) was not independently associated with social relationships (B = 0.12, β = 0.002, 95% CI: −6.628–6.863, p = 0.973). Educational attainment was significantly associated with social relationships. Compared with participants with primary education, those with secondary education (B = 12.01, β = 0.204, 95% CI: 2.754–21.273, p = 0.011) and higher education (B = 17.25, β = 0.311, 95% CI: 7.760–26.729, p < 0.001) had higher social relationships scores. Married or cohabiting participants had higher social relationships scores than single participants (B = 11.31, β = 0.206, 95% CI: 4.565–18.060, p = 0.001), whereas divorced or widowed participants had lower scores (B = −14.37, β = −0.169, 95% CI: −24.084–−4.657, p = 0.004). Sex, age group, employment status, multimorbidity, and number of medications were not significantly associated with social relationships (p > 0.05).
Diagnostic assessment indicated that the assumptions underlying the multiple linear regression models were reasonably satisfied. Normal P–P plots showed an approximately linear alignment of the standardized residuals with the expected normal distribution, although minor deviations were observed in some models. Scatterplots of standardized residuals against standardized predicted values did not indicate a pronounced systematic pattern, supporting the assumptions of linearity and homoscedasticity. Standardized residuals ranged from −3.025–2.332 across the five models. Durbin–Watson statistics ranged from 1.516–1.949, indicating no substantial concern regarding residual independence. Collinearity diagnostics showed tolerance values ranging from 0.305–0.893 and VIF values from 1.120–3.283, indicating no evidence of problematic multicollinearity.
4. Discussion
The present study investigated the association between MA and QoL among adults with chronic conditions or multimorbidity attending primary healthcare centers in Albania. Three main findings emerged. First, MA was low, with fewer than one-quarter of participants classified as adherent. Second, adherent participants reported significantly better QoL, particularly in the physical health, psychological health, and Environmental domains. Third, in the multivariable analyses, medication adherence (MA) remained independently associated with overall QoL, psychological health, and environmental health, but not with physical health or social relationships. Educational attainment was consistently associated with higher QoL across the regression models, while multimorbidity and number of medications were not independently associated with the QoL outcomes.
This cross-sectional study included 395 adults with one chronic condition or multimorbidity recruited from six primary healthcare centers in Vlorë and Orikum, Albania. The study population was predominantly female, with most participants having completed higher education and being employed. Approximately four out of five participants reported living with a single chronic condition, while one-fifth had multimorbidity. Hypertension was the most prevalent condition, followed by allergies and diabetes mellitus, and antihypertensive medications were the most frequently prescribed treatment. Most participants reported taking no more than two medications daily, indicating that complex medication regimens were relatively uncommon within the study population.
The predominance of participants with a single chronic condition, together with the high prevalence of hypertension and the relatively limited use of multiple daily medications, represents key characteristics of the study population that should be considered when evaluating the subsequent analyses of adherence and quality-of-life outcomes.
4.1. Medication Adherence and Its Associated Factors
The present study found that only 22.5% of participants were adherent–their prescribed medications, whereas 77.5% were classified as non-adherent, highlighting the substantial burden of medication non-adherence among individuals with chronic diseases.
These findings are broadly consistent with previous international research highlighting medication non-adherence as a significant challenge in chronic disease management. Foley et al. (2021) [18], in a systematic review and meta-analysis, reported a pooled non-adherence prevalence of 42.6% among individuals with multimorbidity. However, the authors found inconsistent associations between the number of prescribed medications and non-adherence. Therefore, although our findings suggest that a higher medication burden is associated with lower adherence, differences in study populations and assessment methods should be considered when interpreting these results.
MA was significantly higher among younger participants, individuals with higher educational attainment, those with a single chronic condition, and participants taking up–two medications per day. Marital status was also significantly associated with adherence, with a higher proportion of adherent participants among those who were single. After adjustment for sex, age, education, employment, marital status, multimorbidity, and number of medications, educational attainment, marital status, and number of medications remained independently associated with medication adherence. Participants with secondary or lower educational attainment had lower odds of adherence than those with higher education. The bivariate association with age did not remain statistically significant after multivariable adjustment, suggesting that the observed age differences in adherence may partly reflect differences in other sociodemographic or treatment-related characteristics. These findings are partially consistent with those reported by Tavares et al. (2016) [19], who identified a greater medication taking per day and the presence of multiple chronic conditions as factors associated with lower medication adherence in a Brazilian population.
Although single participants had a higher proportion of adherence in the bivariate analysis, married or cohabiting participants had higher adjusted odds of adherence in the multivariable model. This difference suggests that the association between marital status and adherence was influenced by the other variables included in the adjusted model. This finding may be related–the potential role of social and family support in medication-taking behavior, as suggested by previous literature [6].
Medications taking per day, was also independently associated with adherence, with participants taking up–two medications per day demonstrating nearly fivefold higher odds of adherence than those prescribed more complex regimens. This finding is consistent with previous evidence suggesting that increasing treatment complexity may adversely affect MA.
No significant association between sex and MA was observed, supporting previous evidence that sex alone is not a consistent predictor of adherence behavior. Similarly, age, employment status, and multimorbidity were not independently associated with adherence after multivariable adjustment.
Although previous studies used adherence assessment instruments other than the SMAQ questionnaire, the consistency of the identified determinants across different measurement tools strengthens the evidence that educational attainment, social support, and medications taking per day, are relevant predictors of MA rather than findings attributable solely–a specific measurement instrument. In this context, the present study also contributes–the limited evidence on MA among adults in Albania, particularly younger adults, for whom data remain relatively scarce. The use of the SMAQ questionnaire provides a standardized approach for assessing adherence and may facilitate further research on medication-taking behavior in different adult populations.
Recent Albanian research provides an important contextual comparison. Subashi et al. (2026) [4] examined multiple chronic conditions and multimorbidity among older adults in southern Albania, representing a substantially different population from the adults aged 18–64 years included in the present study. Differences in age, clinical characteristics, and study context should therefore be considered when comparing the findings. The present study complements this evidence by examining medication adherence and quality of life among a broader adult primary healthcare population, including younger adults.
4.2. Quality of Life and Its Association with Medication Adherence
Among the WHOQOL-BREF domains, psychological health showed the highest mean score, whereas the physical health, environmental, and social relationships domains demonstrated comparable but lower scores. No significant differences in QoL were observed between participants with a single chronic condition and those with multimorbidity across any WHOQOL-BREF domain. This finding indicates that multimorbidity was not associated with differences in QoL in the bivariate comparisons in the present study.
In contrast, MA was significantly associated with better QoL in the bivariate analysis. Participants who were adherent–their prescribed medications reported significantly higher overall QoL, greater satisfaction with their health, and higher scores in the physical health, psychological health, and environmental domains compared with non-adherent participants. These findings are consistent with previous evidence. Likaj et al. (2025) [20] reported that better MA was associated with improved QoL among adults with chronic diseases, particularly in physical and psychological dimensions, while Lee et al. (2022) [12] similarly observed higher overall QoL among patients with greater MA. The absence of a significant association in the social relationship’s domain may indicate that this dimension is influenced more strongly by interpersonal, social, and socioeconomic factors than by medication-taking behavior alone.
Notably, the association between medication adherence and quality of life was not consistent across all WHOQOL-BREF domains. Although medication adherence (MA) was significantly associated with overall quality of life, satisfaction with health, physical health, psychological health, and environmental health, no significant association was observed for the social relationship’s domain. This finding highlights the multidimensional nature of quality of life and suggests that social relationships may be influenced by broader interpersonal and contextual factors beyond medication-taking behavior.
The multivariable analyses further indicated that the association between medication adherence and QoL was domain-specific. In the model of overall QoL, medication adherence, educational attainment, age group, and marital status were independently associated with QoL. Adherent participants reported higher overall QoL, while participants with secondary or higher education had higher scores than those with primary education. Participants aged 35–44 years reported lower overall QoL than those aged 18–24 years, whereas married or cohabiting participants reported higher scores than single participants. Neither multimorbidity nor the number of medications was independently associated with overall QoL. Across the four WHOQOL-BREF domains, medication adherence (MA) remained independently associated with psychological health and environmental health, but not with physical health or social relationships. Educational attainment showed a consistent positive association across all four domains. These findings highlight the multidimensional nature of QoL and indicate that the association between medication adherence (MA) and QoL is not uniform across all QoL dimensions. The observed associations between educational attainment, age, medication adherence (MA), and QoL are broadly consistent with previous research identifying these factors as relevant correlates of QoL among adults living with chronic conditions [19,20]. Kangas et al. (2025) [9] identified educational attainment as an important factor associated with better QoL among people living with chronic conditions, while Teli et al. (2023) [21] reported associations between educational and sociodemographic characteristics, medication adherence (MA) and QoL among adults with chronic conditions.
Recent Albanian evidence provides an important contextual comparison. Subashi et al. (2026) [4], in a multicenter study of 727 adults aged ≥65 years with multiple chronic conditions in southern Albania, reported that multimorbidity was associated with medication non-adherence and reduced QoL. However, the study population differed substantially from that of the present study, which included adults aged 18–64 years with either one chronic condition or multimorbidity. In addition, Subashi et al. (2026) [4], used the Older People’s Quality of Life Questionnaire (OPQOL-35), whereas the present study used the WHOQOL-BREF. These differences in age, clinical complexity, study population, and QoL measurement should be considered when comparing the findings. The present study therefore complements the existing Albanian evidence by examining medication adherence and QoL in a broader adult primary-care population, including younger adults.
In the overall QoL model, sex, employment status, multimorbidity, and number of medications were not independently associated with QoL after adjustment for the other variables. Previous research has reported heterogeneous associations between sociodemographic and clinical characteristics and health-related QoL. Kangas et al. (2025) [9] identified educational attainment as a consistent determinant of better QoL among people living with chronic conditions, whereas associations with age, sex, employment, and marital status varied across studies. Teli et al. (2023) [21] similarly identified education, age, marital status, comorbidities, and medication adherence (MA) as factors associated with health-related QoL among adults with type 2 diabetes. Thus, in the present study, medication adherence (MA) and educational attainment remained particularly relevant factors associated with overall QoL after multivariable adjustment.
The absence of a significant association between multimorbidity and QoL in the present study contrasts with evidence suggesting that multimorbidity is generally associated with poorer QoL, particularly in the physical domain (Makovski et al., 2019) [22]. Differences in participant characteristics, disease severity, duration and combinations of chronic conditions, healthcare settings, and quality-of-life assessment instruments may partially explain these discrepant findings. This interpretation is also relevant when comparing the present results with Subashi et al. (2026) [4], whose study specifically examined older adults with multiple chronic conditions and found that multimorbidity was associated with greater clinical and functional complexity and reduced QoL. Therefore, the absence of an association between multimorbidity and QoL in the present adult population should not be interpreted as evidence that multimorbidity has no impact on QoL. Rather, it may indicate that the relationship is influenced by other factors, including age, educational level, MA, disease characteristics, and the complexity of chronic conditions.
Overall, the present findings emphasize the importance of considering medication adherence and educational attainment when examining QoL among adults with chronic conditions. The observed associations between medication adherence (MA) and selected QoL outcomes are broadly consistent with previous international evidence, while the findings from the present study provide additional evidence from the Albanian primary healthcare context. At the same time, the lack of an independent association between multimorbidity and QoL in this study highlights the need for further research examining how condition severity, specific combinations of chronic conditions, treatment complexity, and social determinants interact–influence QoL among Albanian adults.
4.3. Strength
A major strength and distinctive contribution of the present study is that, –the best of our knowledge, it is the first study in Albania–simultaneously examine the interrelationships between chronic conditions, multimorbidity, MA, and QoL across a broader adult population, including younger adults. Previous Albanian research has primarily focused on specific chronic conditions, MA, or older adults. Most recently, Subashi et al. (2026) [4] examined multimorbidity and MA among adults aged ≥ 65 years in southern Albania. The present study therefore extends the existing Albanian evidence by investigating these interconnected factors in a broader adult population and provides novel evidence on their relationships beyond the older-adult population. In addition, the study examined the four WHOQOL-BREF domains and used multivariable regression analyses to assess independent associations after adjustment for relevant sociodemographic and clinical characteristics.
4.4. Limitations
Several limitations should be considered when interpreting the findings. First, the cross-sectional design prevents the establishment of temporal or causal relationships between MA, multimorbidity, and QoL.
Second, participants were recruited through non-probability consecutive sampling from primary healthcare centers in one of the biggest cities in the South of Albania, which may limit the generalizability of the findings to other regions, healthcare settings, and populations.
Third, since the study data were collected through self-reported questionnaires, the findings may be subject to recall and social desirability bias. In particular, medication adherence was assessed using the self-reported SMAQ, which relies on participants’ subjective reporting of their medication-taking behaviors and may therefore be influenced by individual perceptions and reporting tendencies.
Furthermore, the study population included a relatively high proportion of participants with a single chronic condition and a relatively low medication burden, which may limit the applicability of the findings to patients experiencing more complex multimorbidity and polypharmacy.
Finally, the regression model accounted for only a modest proportion of the variance in overall QoL, suggesting that additional clinical, psychosocial, behavioral, and socioeconomic factors not assessed in the present study may also contribute to quality-of-life outcomes.
5. Conclusions
In conclusion, medication non-adherence was highly prevalent among adults with chronic conditions receiving care in primary healthcare settings in Albania. In the bivariate analyses, participants classified as adherent reported significantly better overall quality of life, greater satisfaction with health, and higher physical health, psychological health, and environmental health scores, whereas no significant difference was observed for social relationships. In the multivariable analyses, medication adherence (MA) remained independently associated with overall quality of life, psychological health, and environmental health, but not with physical health or social relationships. Higher educational attainment was consistently associated with better quality of life across multiple dimensions, while multimorbidity and the number of medications taken per day were not independently associated with quality-of-life outcomes. Given the cross-sectional design, these findings should be interpreted as associations rather than causal effects. Longitudinal research is warranted to clarify the temporal relationship between medication adherence (MA) and quality of life and–further examine the factors contributing to quality-of-life outcomes.
Author Contributions
Conceptualization, S.L. and E.A.M.; methodology, S.L. and E.A.M.; formal analysis, E.K. and S.L.; investigation, S.L., E.A.M. and E.V.; data curation, S.L. and E.K.; resources, S.L. and B.S.; validation, E.A.M.; supervision, E.A.M.; visualization, S.L. and E.K.; writing—original draft preparation, S.L.; writing—review and editing, S.L., E.A.M., E.V., B.S. and E.K. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Regional Directorate of the Vlorë Healthcare Services Operator, approved under Protocol Code no. 2629/1, approval date 26 November 2024.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.
Data Availability Statement
The data supporting this research are available from the author(s) on reasonable request.
Conflicts of Interest
The authors declare no conflicts of interest.
Abbreviations
The following abbreviations are used in this manuscript:
| MA | Medication Adherence |
| QoL | Quality of Life |
| WHO | World Health Organization |
| SMAQ | Simplified Medication Adherence Questionary |
| WHOQOL-BREF | The World Health Organization Quality of Life Questionnaire–Brief Version |
| AORs | Adjusted odds ratios |
References
- World Health Organization. Noncommunicable Diseases; World Health Organization: Geneva, Switzerland, 2025. [Google Scholar]
- Albanian Institute of Public Health. National Health Report; Health Status of the Albanian Population: Tirana, Albania, 2014.
- Kraja, F.; Kraja, B.; Mone, I.; Harizi, I.; Babameto, A.; Burazeri, G. Self-reported Prevalence and Risk Factors of Non-communicable Diseases in the Albanian Adult Population. Med. Arch. 2016, 70, 208–212. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Subashi, B.; Kamberi, F.; Kokalla, E. Multiple Chronic Conditions and Multimorbidity Among Older Adults in Southern Albania: Distribution and Impact on Care Needs, Medication Adherence, and Quality of Life. Healthcare 2026, 14, 2058. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Osterberg, L.; Blaschke, T. Adherence to medication. N. Engl. J. Med. 2005, 353, 487–497. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chen, Y.; Gao, J.; Lu, M. Medication adherence trajectory of patients with chronic diseases and its influencing factors: A systematic review. J. Adv. Nurs. 2024, 80, 11–41. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sabaté, E. (Ed.) Adherence to Long-Term Therapies: Evidence for Action; World Health Organization: Geneva, Switzerland, 2003. [Google Scholar]
- Folkvord, F.; Würth, A.R.; van Houten, K.; Liefveld, A.R.; Carlson, J.I.; Bol, N.; Krahmer, E.; Beets, G.; Ollerton, R.D.; Turk, E.; et al. A systematic review on experimental studies about patient adherence to treatment. Pharmacol. Res. Perspect. 2024, 12, e1166. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Kangas, T.; Milis, S.L.; Vanthomme, K.; Vandenheede, H. The social determinants of health-related quality of life among people with chronic disease: A systematic literature review. Qual. Life Res. 2025, 34, 2501–2511. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Skou, S.T.; Mair, F.S.; Fortin, M.; Guthrie, B.; Nunes, B.P.; Miranda, J.J.; Boyd, C.M.; Pati, S.; Mtenga, S.; Smith, S.M. Smith Multimorbidity. Nat. Rev. Dis. Prim. 2022, 8, 48. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Khayyat, S.M.; Mohamed, M.M.A.; Khayyat, S.M.S.; Hyat Alhazmi, R.S.; Korani, M.F.; Allugmani, E.B.; Saleh, S.F.; Mansouri, D.A.; Lamfon, Q.A.; Beshiri, O.M.; et al. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: A cross-sectional survey. Qual. Life Res. 2019, 28, 1053–1061. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lee, Y.; Ahn, Y.; Cucullo, L. Impact of physical activity and medication adherence on the seizure frequency and quality of life of epileptic patients: A population study in West Texas. BioMed Res. Int. 2022, 2022, 4193664. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kavvadia, M.; Saridi, M.; Toska, A.; Bakalis, V.; Zetta, S.; Paralikas, T.; Sarafis, P.; Fradelos, E.C. The effect of medication adherence and spirituality in quality of life of patients with rheumatic diseases. Healthcare 2025, 13, 436. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 2024. Available online: https://www.wma.net/policies-post/wma-declaration-of-helsinki/ (accessed on 15 October 2026).
- Knobel, H.; Alonso, J.; Casado, J.L.; Collazos, J.; González, J.; Ruiz, I.; Kindelan, J.M.; Carmona, A.; Juega, J.; Ocampo, A. GEEMA Study Group. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS 2002, 16, 605–613. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 1998, 28, 551–558. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Skevington, S.M.; Lotfy, M.; O’Connell, K.A.; WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual. Life Res. 2004, 13, 299–310. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Foley, L.; Larkin, J.; Lombard-Vance, R.; Murphy, A.W.; Hynes, L.; Galvin, E.; Molloy, G.J. Prevalence and predictors of medication non-adherence among people living with multimorbidity: A systematic review and meta-analysis. BMJ Open 2021, 11, e044987, Correction in BMJ Open 2022, 12, e044987corr1. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tavares, N.U.L.; Bertoldi, A.D.; Mengue, S.S.; Arrais, P.S.D.; Luiza, V.L.; Oliveira, M.A.; Ramos, L.R.; Farias, M.R.; Pizzol, T.d.S.D. Factors associated with low adherence to medicine treatment for chronic diseases in Brazil. Rev. Saúde Pública 2016, 50, 10s. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Likaj, S.; Subashi, B.; Kokalla, E.; Kicaj, E.; Mechili, E.A. Impact of Medication Adherence and Quality of Life in Adults With a Single Chronic Condition or Multimorbidity: A Narrative Review. Inferm. J. 2025, 4, 199–209. [Google Scholar] [CrossRef] [Scilit]
- Teli, M.; Thato, R.; Rias, Y.A. Predicting Factors of Health-Related Quality of Life Among Adults With Type 2 Diabetes: A Systematic Review. SAGE Open Nurs. 2023, 9, 23779608231185921, Erratum in SAGE Open Nurs. 2023, 9, 23779608231202935. https://doi.org/10.1177/23779608231202935. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Makovski, T.T.; Schmitz, S.; Zeegers, M.P.; Stranges, S.; van den Akker, M. Multimorbidity and quality of life: Systematic literature review and meta-analysis. Ageing Res. Rev. 2019, 53, 100903. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.